Quantcast

Latest Ciprofloxacin Stories

2010-05-18 09:00:00

SAN DIEGO, May 18 /PRNewswire/ -- Attorneys representing plaintiffs who overpaid for the antibiotic Cipro are asking a California appellate court to reverse a lower court ruling that set aside antitrust claims against Bayer Corporation. The case involves the agreement Bayer made with generic competitors to prevent competition and to maintain Cipro prices at high levels. The plaintiffs are a certified class of California consumers, union health and welfare funds, and others. In their...

2010-04-26 08:41:01

The use of antibiotics to treat bacterial infections causes a continual and vicious cycle in which antibiotic treatment leads to the emergence and spread of resistant strains, forcing the use of additional drugs leading to further multi-drug resistance. But what if it doesn't have to be that way? In a presentation at the American Society for Biochemistry and Molecular Biology's annual meeting, titled "Driving backwards the evolution of antibiotic resistance," Harvard researcher Roy Kishony...

2010-03-11 08:00:00

WAYNE, N.J., March 11 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration (FDA) for ciprofloxacin dry powder inhaler (DPI) for management of pulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis (CF) patients. A similar designation has already been granted by the European Medicines Agency. Ciprofloxacin DPI is an investigational drug-device combination that combines...

2010-02-12 13:54:00

PITTSBURGH, Feb. 12 /PRNewswire/ -- Pittsburgh-based food and fuel retailer Giant Eagle, Inc. launched its free antibiotics program in September of 2009, and is pleased to announce that the program has resulted in more than $3 million in free prescriptions for customers in the company's four-state operating area. To date, more than 590,000 prescriptions for free antibiotics have been filled by the Giant Eagle Pharmacy, treating common infections that range from strep throat, ear...

cee23c797b474d583ad55cf60dadac031
2010-02-10 12:39:12

Mutations that enable Pseudomonas to thrive in cystic fibrosis lung secretions may also guard the bacteria against antibiotics People with cystic fibrosis, an inherited disease that clogs airways with thick mucous, frequently have lung infections that defy treatment. While the life expectancy for children with cystic fibrosis has increased over the past few decades, many lives are still shortened in young adulthood by the ravages of lung infections. These chronic infections are often caused...

2009-11-18 11:14:00

NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Antibiotics - Global Trends http://www.reportlinker.com/p0164263/Antibiotics---Global-Trends.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire Long-term growth in the global antibiotics market would be affected by two major factors - antibiotic resistance and generic competition. Antibiotic resistance, which compels reduction in the usage...

2009-11-15 12:18:59

Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow. Just as some drugs work better together, however, other pairings are counter-productive. "The question we asked was how can it be that two drugs in combination are less effective than one of them alone," said senior author...

2009-10-01 09:27:00

Drug Giant Tries to Silence CSPI With Threat of Libel Suit WASHINGTON, Oct. 1 /PRNewswire-USNewswire/ -- The Center for Science in the Public Interest has sued the German drug company Bayer for falsely claiming that the selenium in Men's One A Day multivitamins might reduce the risk of prostate cancer. The lawsuit is filed in the Superior Court of California in San Francisco. CSPI first contacted Bayer in June to demand that the drug maker alter its marketing of Men's One A Day...

2009-09-14 13:15:00

SAN DIEGO, Sept. 14 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced the presentation of results from its second prulifloxacin Phase 3 clinical study for the treatment of infectious diarrhea in travelers, by clinical investigator Robert Steffen, M.D., at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco. (Logo: http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO) Dr. Steffen presented the...

2009-09-14 10:00:00

NEW HAVEN, Conn., Sept. 14 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of multi-antibiotic resistant infections, today announced that it intends to enter into a Clinical Trials Agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services. The...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.